Project Details
Project Description
The aim of Monash and partner organisation ULVAC is to develop new technology for producing tuneable vertically aligned silicon nanotube (VA-SiNT) arrays with adaptable architecture and surface chemistry, and to demonstrate that this can be used as a highly efficient, universal, and scalable intracellular delivery and sampling platform, with significant prospects for clinical translation.
Status | Active |
---|---|
Effective start/end date | 1/06/18 → 30/06/21 |
Funding
- Ulvac Inc: AUD100,000.00